Page last updated: 2024-09-03

afdx 384 and Weight Gain

afdx 384 has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deng, C; Han, M; Huang, XF; Weston-Green, KL	1

Other Studies

1 other study(ies) available for afdx 384 and Weight Gain

Article	Year
Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats. Progress in neuro-psychopharmacology & biological psychiatry, 2007, May-09, Volume: 31, Issue:4 Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Binding, Competitive; Female; Gene Expression Regulation; Medulla Oblongata; Olanzapine; Parasympatholytics; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium; Weight Gain	2007

Article

Year

Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats.

Progress in neuro-psychopharmacology & biological psychiatry, 2007, May-09, Volume: 31, Issue:4

Topics: Animals; Antipsychotic Agents; Autoradiography; Benzodiazepines; Binding, Competitive; Female; Gene Expression Regulation; Medulla Oblongata; Olanzapine; Parasympatholytics; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Tritium; Weight Gain

2007